139 related articles for article (PubMed ID: 30269573)
1. Weight gain correlated with decrease in clozapine/N-desmethyl-clozapine ratio in a man with treatment-refractory schizophrenia.
De Mel VN; Korman N; McArdle P; Siskind DJ
Australas Psychiatry; 2018 Oct; 26(5):558-559. PubMed ID: 30269573
[No Abstract] [Full Text] [Related]
2. Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances.
Lu ML; Lane HY; Lin SK; Chen KP; Chang WH
J Clin Psychiatry; 2004 Jun; 65(6):766-71. PubMed ID: 15291653
[TBL] [Abstract][Full Text] [Related]
3. Pancreatitis associated with metformin used for management of clozapine-related weight gain.
McFadden M; Gordon A; Leong G; Ward D; Scott JG
Aust N Z J Psychiatry; 2016 Jul; 50(7):701-2. PubMed ID: 26883571
[No Abstract] [Full Text] [Related]
4. Weight gain induced by clozapine.
Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
Eur Neuropsychopharmacol; 1995 Dec; 5(4):437-40. PubMed ID: 8998394
[TBL] [Abstract][Full Text] [Related]
5. Weight gain among schizophrenic patients treated with clozapine.
Lamberti JS; Bellnier T; Schwarzkopf SB
Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460
[TBL] [Abstract][Full Text] [Related]
6. Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment.
Monteleone P; Fabrazzo M; Tortorella A; La Pia S; Maj M
J Clin Psychopharmacol; 2002 Aug; 22(4):424-6. PubMed ID: 12172344
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in psychosis.
Collier DA
Drug News Perspect; 2003 Apr; 16(3):159-65. PubMed ID: 12819814
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
[TBL] [Abstract][Full Text] [Related]
9. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.
Basile VS; Masellis M; De Luca V; Meltzer HY; Kennedy JL
Lancet; 2002 Nov; 360(9347):1790-1. PubMed ID: 12480467
[No Abstract] [Full Text] [Related]
10. Festina Lente: Betahistine for Clozapine-Associated Weight Gain: A Case Report.
Suhas S; Shivani S; Singh GK; Venkatasubramanian G
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):332-333. PubMed ID: 33843821
[No Abstract] [Full Text] [Related]
11. Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study.
Sporn AL; Bobb AJ; Gogtay N; Stevens H; Greenstein DK; Clasen LS; Tossell JW; Nugent T; Gochman PA; Sharp WS; Mattai A; Lenane MC; Yanovski JA; Rapoport JL
J Am Acad Child Adolesc Psychiatry; 2005 Sep; 44(9):925-33. PubMed ID: 16113621
[TBL] [Abstract][Full Text] [Related]
12. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
[TBL] [Abstract][Full Text] [Related]
13. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
14. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
[TBL] [Abstract][Full Text] [Related]
15. INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine.
Koskinen S; Kampman O; Solismaa A; Lyytikäinen LP; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E
Pharmacogenomics; 2016 Dec; 17(18):1987-1997. PubMed ID: 27885961
[TBL] [Abstract][Full Text] [Related]
16. Weight Loss During Atomoxetine Add-on to Clozapine-Responsive Schizophrenia.
Naguy A; Alamiri B; Khraibut B
Am J Ther; 2018; 25(6):e774-e775. PubMed ID: 29782344
[No Abstract] [Full Text] [Related]
17. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
[TBL] [Abstract][Full Text] [Related]
18. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
[TBL] [Abstract][Full Text] [Related]
19. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment.
Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ
Hum Psychopharmacol; 2010; 25(4):303-9. PubMed ID: 20521320
[TBL] [Abstract][Full Text] [Related]
20. Reversal of weight gain with concurrent normalization of fasting glucose and marked reduction in triglyceride after clozapine dose-reduction and simplification of other psychotropics in chronic schizophrenia: a case report.
Yu CH
Psychiatr Danub; 2014 Jun; 26(2):190-2. PubMed ID: 24909258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
